Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434253/all/Pharmacological_interventions_for_preventing_complications_in_idiopathic_hypercalciuria_New. Accessed 18 April 2024.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434253/all/Pharmacological_interventions_for_preventing_complications_in_idiopathic_hypercalciuria_New. Accessed April 18, 2024.
Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434253/all/Pharmacological_interventions_for_preventing_complications_in_idiopathic_hypercalciuria_New
Oral Versus Intravenous Steroids for Treatment of Relapses in Multiple Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434253/all/Pharmacological_interventions_for_preventing_complications_in_idiopathic_hypercalciuria_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
ID - 434253
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434253/all/Pharmacological_interventions_for_preventing_complications_in_idiopathic_hypercalciuria_New
DB - Evidence Central
DP - Unbound Medicine
ER -